A Quick Look at Today's Ratings for Fortrea Holdings(FTRE.US), With a Forecast Between $21 to $30
Hold Rating on Fortrea Holdings Amid Contracting Challenges and Revised Financial Guidance
Fortrea Holdings Price Target Cut to $30.00/Share From $42.00 by Citigroup
A Quick Look at Today's Ratings for Fortrea Holdings(FTRE.US), With a Forecast Between $21 to $30
Evercore ISI Remains a Hold on Fortrea Holdings Inc. (FTRE)
Fortrea Holdings Inc.: Underperform Rating Maintained Amid Downward Financial Revisions and Market Challenges
Fortrea Holdings Inc. (FTRE) Gets a Hold From Barclays
Fortrea Holdings Analyst Ratings
Evercore Cuts Fortrea to in Line, Cites Weakening Macro Environment
Evercore ISI Group Downgrades Fortrea Holdings to In-Line, Lowers Price Target to $27
Fortrea Holdings Price Target Announced at $30.00/Share by Barclays
Fortrea Holdings Analyst Ratings
Barclays Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Maintains Target Price $30
Barclays Downgrades Fortrea Holdings(FTRE.US) to Hold Rating, Cuts Target Price to $30
Fortrea Holdings Analyst Ratings
Analysts Offer Insights on Healthcare Companies: InMode (INMD), Fortrea Holdings Inc. (FTRE) and Lexeo Therapeutics, Inc. (LXEO)
Fortrea Holdings Analyst Ratings
Fortrea Holdings Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Fortrea Holdings Inc. (FTRE) and Cellectis SA (CLLS)
Fortrea Holdings Analyst Ratings